Press Releases and News

Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit

March 13, 2019

We have just returned from the Biotherapeutics Analytical Summit in Virginia. What a great celebration of the conference’s 10th birthday! We were inundated with fascinating conversations, the most popular being the characterization of higher order structure (or HOS). We presented a poster with Elion Labs on the study of HOS of IgG Samples Spiked with … “Higher Order Structure: The Hot Topic of Biotherapeutics Analytical Summit”

READ MORE

RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)

February 15, 2019

Critical Quality Attributes to Advance Therapeutics and Vaccines from Candidate Selection to Drug Product Biotherapeutics and vaccines are critical in improving public health. They are being developed for acute and chronic clinical indications that cover the spectrum from infectious diseases to oncology. The development of biologics, from candidate engineering and selection, through expression, purification, formulation, … “RedShiftBio Joined Thought Leaders at Biotherapeutics and Vaccines Development (Gordon Research Conference)”

READ MORE

RedShiftBio Shines at PepTalk 2019

February 15, 2019

We were excited to exhibit at PepTalk 2019 for the first time. PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. The international delegation of over 1,300 participants attended for intensive learning and networking to discover new opportunities, apply alternative solutions, and develop promising partnerships. … “RedShiftBio Shines at PepTalk 2019”

READ MORE

AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019

February 15, 2019

The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products. Our AQS3proTM  was a cutting edge addition … “AQS³pro: a cutting edge addition to the bioanalytical technologies showcased at WCBP 2019”

READ MORE

RedShiftBio’s  AQS³pro: Finalist in The Prism Awards 2019

January 30, 2019

RedShift™ BioAnalytics, Inc. (RedShiftBio™) announces that the AQS3pro has been named as a finalist in the Prism Awards 2019. The Prism Awards recognize outstanding examples and innovative products that are changing lives for the better. This year was quoted by one of the judges to be “an exceptional year of exceptional products”.

READ MORE

Complex Protein Studies Demand Dynamic Techniques

October 5, 2018

Biopharm International interviews scientists with experience of Microfluidic Modulation Spectroscopy for a round-table on how complex protein studies demand dynamic techniques. Visit page 18 to see what Immunogen, Janssen, Elion Labs and the University of Delaware have to say.

READ MORE